Early intraneuronal accumulation and increased aggregation of phosphorylated Abeta in a mouse model of Alzheimer's disease

Acta Neuropathologica

Volumn 125, Issue 5, 2013, Pages 699-709

  Kumar, Sathish ^a   Wirths, Oliver ^b   Theil, Sandra ^a   Gerth, Janina ^a   Bayer, Thomas A ^b   Walter, Jochen ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Alzheimer; Intraneuronal Abeta; Phospho amyloid; Phosphorylation; Post translational modification; Transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN; PHOSPHOSPECIFIC ANTIBODY; SERINE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SUBICULUM; AGE; ANIMAL; DISEASE MODEL; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TRANSGENIC MOUSE;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; NEURONS; PHOSPHORYLATION; PLAQUE, AMYLOID;

EID: 84886703257     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-013-1107-8     Document Type: Article

References (51)

1. Abramowski D, Rabe S, Upadhaya AR, Reichwald J, Danner S et al (2012) Transgenic expression of intraneuronal Abeta42 but not Abeta40 leads to cellular Abeta lesions, degeneration, and functional impairment without typical Alzheimer's disease pathology. J Neurosci 32:1273-1283
2. Bayer TA, Wirths O (2010) Intracellular accumulation of amyloid- Beta - a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front Aging Neurosci 2:8
3. Bayer TA, Wirths O (2011) Intraneuronal Abeta as a trigger for neuron loss: can this be translated into human pathology? Biochem Soc Trans 39:857-861
4. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45:675-688
5. Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O et al (2004) Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol 165:1289-1300
6. Christensen DZ, Kraus SL, Flohr A, Cotel MC, Wirths O, Bayer TA (2008) Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Acta Neuropathol 116:647-655
7. Crowther DC, Kinghorn KJ, Miranda E, Page R, Curry JA et al (2005) Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 132:123-135
8. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38:120-134
9. Dong J, Atwood CS, Anderson VE, Siedlak SL, Smith MA et al (2003) Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: raman microscopic evidence. Biochemistry 42:2768-2773
10. Echeverria V, Ducatenzeiler A, Dowd E, Janne J, Grant SM et al (2004) Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience 129:583-592
11. Glenner GG, Wong CW (2012) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. 1984. Biochem Biophys Res Commun 425:534-539
12. Gouras GK, Almeida CG, Takahashi RH (2005) Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26:235-1244
13. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M et al (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156:15-20
14. Gouras GK, Willen K, Tampellini D (2012) Critical role of intraneuronal Abeta in Alzheimer's disease: technical challenges in studying intracellular Abeta. Life Sci 91:1153-1158
15. Gyure KA, Durham R, Stewart WF, Smialek JE, Troncoso JC (2001) Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 125:489-492
16. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G et al (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci USA 96:3228-3233
17. Iwatsubo T, Saido TC, Mann DM, Lee VM, Trojanowski JQ (1996) Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Am J Pathol 149:1823-1830
18. Jawhar S, Wirths O, Bayer TA (2011) Pyroglutamate amyloidbeta (Abeta): a hatchet man in Alzheimer disease. J Biol Chem 286:38825-38832
19. Kumar S, Rezaei-Ghaleh N, Terwel D, Thal DR, Richard M et al (2011) Extracellular phosphorylation of the amyloid beta-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease. EMBO J 30:2255-2265
20. Kumar S, Singh S, Hinze D, Josten M, Sahl HG et al (2012) Phosphorylation of amyloid-beta peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes. J Biol Chem 287:8641-8651
21. Kumar S, Walter J (2011) Phosphorylation of amyloid beta (Abeta) peptides - a trigger for formation of toxic aggregates in Alzheimer's disease. Aging (Albany NY) 3:803-812
22. Kummer MP, Hermes M, Delekarte A, Hammerschmidt T, Kumar S et al (2011) Nitration of tyrosine 10 critically enhances amyloid beta aggregation and plaque formation. Neuron 71:833-844
23. Kuo YM, Kokjohn TA, Beach TG, Sue LI, Brune D et al (2001) Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains. J Biol Chem 276:12991-12998
24. Lansbury PT Jr (1997) Structural neurology: are seeds at the root of neuronal degeneration? Neuron 19:1151-1154
25. Li M, Chen L, Lee DH, Yu LC, Zhang Y (2007) The role of intracellular amyloid beta in Alzheimer's disease. Prog Neurobiol 83:131-139
26. Lott IT (2012) Neurological phenotypes for down syndrome across the life span. Prog Brain Res 197:101-121
27. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci 16:5795-5811
28. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and down syndrome. Proc Natl Acad Sci USA 82:4245-4249
29. Milton NG (2001) Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase. NeuroReport 12:3839-3844
30. Milton NG (2005) Phosphorylated amyloid-beta: the toxic intermediate in alzheimer's disease neurodegeneration. Subcell Biochem 38:381-402
31. Mori C, Spooner ET, Wisniewsk KE, Wisniewski TM, Yamaguch H et al (2002) Intraneuronal Abeta42 accumulation in down syndrome brain. Amyloid 9:88-102
32. Mori H, Ishii K, Tomiyama T, Furiya Y, Sahara N et al (1994) Racemization: its biological significance on neuropathogenesis of Alzheimer's disease. Tohoku J Exp Med 174:251-262
33. Murakami K, Uno M, Masuda Y, Shimizu T, Shirasawa T, Irie K (2008) Isomerization and/or racemization at Asp23 of Abeta42 do not increase its aggregative ability, neurotoxicity, and radical productivity in vitro. Biochem Biophys Res Commun 366:745-751
34. Oakley H, Cole SL, Logan S, Maus E, Shao P et al (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 26:10129-10140
35. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE et al (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409-421
36. Saido TC, Iwatsubo T, Mann DM, Shimada H, Ihara Y, Kawashima S (1995) Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. Neuron 14:457-466
37. Saido TC, Yamao-Harigaya W, Iwatsubo T, Kawashima S (1996) Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain. Neurosci Lett 215:173-176
38. Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M et al (2008) Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology. Nat Med 14:1106-1111
39. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766
40. Shimizu T, Watanabe A, Ogawara M, Mori H, Shirasawa T (2000) Isoaspartate formation and neurodegeneration in Alzheimer's disease. Arch Biochem Biophys 381:225-234
41. Tam JH, Pasternak SH (2012) Amyloid and Alzheimer's disease: inside and out. Can J Neurol Sci 39:286-298
42. Tekirian TL, Saido TC, Markesbery WR, Russell MJ, Wekstein DR et al (1998) N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. J Neuropathol Exp Neurol 57:76-94
43. Teplow DB (1998) Structural and kinetic features of amyloid beta-protein fibrillogenesis. Amyloid 5:121-142
44. Tomiyama T, Asano S, Furiya Y, Shirasawa T, Endo N, Mori H (1994) Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues. J Biol Chem 269:10205-10208
45. Walker LC, Rosen RF, LeVine H III (2008) Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity? Rom J Morphol Embryol 49:5-11
46. Walter J, Kaether C, Steiner H, Haass C (2001) The cell biology of Alzheimer's disease: uncovering the secrets of secretases. Curr Opin Neurobiol 11:585-590
47. Wertkin AM, Turner RS, Pleasure SJ, Golde TE, Younkin SG et al (1993) Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. Proc Natl Acad Sci USA 90:9513-9517
48. Winton MJ, Lee EB, Sun E, Wong MM, Leight S et al (2011) Intraneuronal APP, not free Abeta peptides in 3xTg-AD mice: implications for tau versus Abeta-mediated Alzheimer neurodegeneration. J Neurosci 31:7691-7699
49. Wirths O, Bayer TA (2012) Intraneuronal Abeta accumulation and neurodegeneration: lessons from transgenic models. Life Sci 91:1148-1152
50. Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S et al (2001) Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci Lett 306:116-120
51. Youmans KL, Tai LM, Kanekiyo T, Stine WB Jr, Michon SC et al (2012) Intraneuronal Abeta detection in 5xFAD mice by a new Abeta-specific antibody. Mol Neurodegener 7:8